.jpg)
Third Annual Conference on Brain Metastases
August 19-20, 2021
A Virtual Conference
Register Now
Overview
Join the Society for Neuro-Oncology, and the AANS/CNS Section on Tumors, for the 3rd Annual Conference on Brain Metastases hosted virtually August 19-20, 2021. Click here to view the program for the conference.
Registration
Registration for the conference is open now. Please click here to register today.
Who Should Attend
Neuro-oncologist, medical oncologist, neurosurgeons, radiation oncologist, radiologist, physicians/scientists, clinical and laboratory trainees, allied health professionals, pharmacists, and other medical professionals with an interest in metastatic disease.
Learning Objectives
- Discuss all available treatment options for management of LMD patients.
- Identify methods to assess QOL and any factors that may contribute to a decline in QOL.
- Summarize unique issues in the design of clinical trials for brain metastases.
- Recognize LITT as a treatment option for brain metastases.
- Identify immunotherapy options for treatment of brain metastases.
Topics that will be covered within the program are:
Molecular Biomarkers
Significant Advances in Brain Metastases
Multimodality Treatment of Brain Metastases
Radiation in the Management of Brain Metastases
Tumor Board Discussion
Imaging Biomarkers
Radiation in the Management of Brain Metastases
Neurocognition and Quality of Life Considerations
Role of Systemic Therapy in the Management of Brain Metastases
Clinical Trial Panel Discussion
CME Credits
SNO is currently seeking CME credits for this conference. For CME Content,
click here.
Keynote
Evolving Role of Immunotherapy for Brain Metastases
Kim Margolin
UW School of Medicine
Confirmed Speakers
The list of speakers are currently online. The abstract presenters are currently not included in this list. To view the current list of speakers, please
click here.
Abstracts
The abstract submission deadline has passed. The conference organizers welcome the submission of original research on the following topics:
- Basic Science
- Leptomeningeal Disease
- Clinical Trials
- Medical Therapy (Chemotherapy and Immunotherapy)
- Multimodality
- Radiation
- Surgery
- Other
Accepted abstracts will be published in Neuro-Oncology Advances.
What to Expect
- Lectures, Q&A sessions, and electronic posters.
- Live activities to earn AMA PRA Category 1 Credits™
- Accepted abstracts to be published in SNO's journal, Neuro-Oncology Advances
Scientific Program Co-Chairs
Adrienne Boire
Memorial Sloan Kettering Cancer Center
Paul Kongkham
University of Toronto
Rohan Ramakrishna
Weill Cornell Medicine
David Shultz
University of Toronto